Promiscuous recognition of MR1 drives self-reactive mucosal-associated invariant T cell responses.

Corinne De Gregorio, Marco Lepore, Gennaro De Libero, David K Cole, Raffaele Calogero, Lucia Mori, Marc W van der Kamp, Gurdyal S Besra, Ross A Robinson, Velupillai Srikannathasan, Miriam Hock, Angharad Lloyd, Thomas Gligoris, Daniel Constantin, Verena Schaefer, Andrew Chancellor, Alessandro Vacchini, Rory M Crean, Keith Page, Richard J Suckling, Hemza Ghadbane, Vanessa Tubb, Johanne M Pentier, Vijaykumar Karuppiah, Rodrigo Colombo, Giuliano Berloffa, Aisha Beshirova, Vladimir Nosi, Rahul C Khanolkar, Robert Alan Simmons

Journal: The Journal of experimental medicine 2023;220(9):e20221939

PMID: 37382893

Abstract

Mucosal-associated invariant T (MAIT) cells use canonical semi-invariant T cell receptors (TCR) to recognize microbial riboflavin precursors displayed by the antigen-presenting molecule MR1. The extent of MAIT TCR crossreactivity toward physiological, microbially unrelated antigens remains underexplored. We describe MAIT TCRs endowed with MR1-dependent reactivity to tumor and healthy cells in the absence of microbial metabolites. MAIT cells bearing TCRs crossreactive toward self are rare but commonly found within healthy donors and display T-helper-like functions in vitro. Experiments with MR1-tetramers loaded with distinct ligands revealed significant crossreactivity among MAIT TCRs both ex vivo and upon in vitro expansion. A canonical MAIT TCR was selected on the basis of extremely promiscuous MR1 recognition. Structural and molecular dynamic analyses associated promiscuity to unique TCRβ-chain features that were enriched within self-reactive MAIT cells of healthy individuals. Thus, self-reactive recognition of MR1 represents a functionally relevant indication of MAIT TCR crossreactivity, suggesting a potentially broader role of MAIT cells in immune homeostasis and diseases, beyond microbial immunosurveillance.

© 2023 Chancellor et al.

Address: Experimental Immunology, Department of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.; Immunocore Ltd. , Abingdon, UK.; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.; Department of Biology and Biochemistry, University of Bath, Bath, UK.; Doctoral Training Centre in Sustainable Chemical Technologies, University of Bath , Bath, UK.; School of Biosciences, Institute of Microbiology and Infection, University of Birmingham , Edgbaston, UK.; School of Biochemistry, University of Bristol, Bristol, UK.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.